Učitavanje...
Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County
Background: Several placebo controlled studies have demonstrated the efficacy of infliximab in inflammatory bowel disease (IBD) but the potential toxicity of this new biological compound has been less studied. Aim: To assess the use of infliximab in IBD in a population based cohort, with special emp...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Copyright 2004 by Gut
2004
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1774085/ https://ncbi.nlm.nih.gov/pubmed/15138212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2003.018515 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|